基本信息
浏览量:112
职业迁徙
个人简介
Awards and Honors
Damon Runyon Cancer Research Foundation 2018 - 2021 Damon Runyon Clinical Investigator Award
Doris Duke Charitable Foundation 2018 - 2012 Clinical Scientist Award
V Foundation 2018 - 2020 V Scholar Award
AACR 2014 - 2016 AACR BioOncology Fellowship
Uniting Against Lung Cancer 2014 - 2016 Legacy Award
Bonnie J. Addario Lung Cancer Foundation 2013 Research Grant
Overview
Dr. Blakely is a medical oncologist specializing in the treatment of lung cancer. He received his Bachelor of Science degree in Molecular and Cellular Biology from the University of Washington and attended the Perelman School of Medicine at the University of Pennsylvania in the Medical Scientist Training Program. He completed his Internal Medicine residency at the Hospital of the University of Pennsylvania and trained as a clinical fellow in Medical Oncology at UCSF. His research focuses on understanding the cellular and molecular mechanisms underlying lung cancer resistance to EGFR-, and ALK-targeted therapies, and identifying new targets for molecular-directed therapies. His goal is to translate laboratory-based findings into new treatments for lung cancer patients.
Interests
Non-small cell lung cancer, EGFR, ALK, ROS-1, Cancer Genomics, Targeted Therapies
Damon Runyon Cancer Research Foundation 2018 - 2021 Damon Runyon Clinical Investigator Award
Doris Duke Charitable Foundation 2018 - 2012 Clinical Scientist Award
V Foundation 2018 - 2020 V Scholar Award
AACR 2014 - 2016 AACR BioOncology Fellowship
Uniting Against Lung Cancer 2014 - 2016 Legacy Award
Bonnie J. Addario Lung Cancer Foundation 2013 Research Grant
Overview
Dr. Blakely is a medical oncologist specializing in the treatment of lung cancer. He received his Bachelor of Science degree in Molecular and Cellular Biology from the University of Washington and attended the Perelman School of Medicine at the University of Pennsylvania in the Medical Scientist Training Program. He completed his Internal Medicine residency at the Hospital of the University of Pennsylvania and trained as a clinical fellow in Medical Oncology at UCSF. His research focuses on understanding the cellular and molecular mechanisms underlying lung cancer resistance to EGFR-, and ALK-targeted therapies, and identifying new targets for molecular-directed therapies. His goal is to translate laboratory-based findings into new treatments for lung cancer patients.
Interests
Non-small cell lung cancer, EGFR, ALK, ROS-1, Cancer Genomics, Targeted Therapies
研究兴趣
论文共 150 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
biorxiv(2024)
Nature cancerno. 6 (2024): 938-952
Clinical Lung Cancer (2024)
Current problems in cancer (2024): 101065-101065
Nature communicationsno. 1 (2024): 4871-4871
Collin M Blakely,Anatoly Urisman, Matthew A Gubens,Claire K Mulvey,Greg M Allen, Stephen C Shiboski,Julia K Rotow, Turja Chakrabarti,D Lucas Kerr,Jacqueline V Aredo, Bianca Bacaltos, Megan Gee,
Journal of clinical oncology : official journal of the American Society of Clinical Oncologypp.JCO2400071-JCO2400071, (2024)
openalex(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn